Oxford Biomedica plc

OTCPK:OXBD.F Rapporto sulle azioni

Cap. di mercato: US$551.3m

Oxford Biomedica Gestione

Gestione criteri di controllo 2/4

Oxford Biomedica's CEO is Frank Mathias, appointed in Mar 2023, has a tenure of 1.67 years. total yearly compensation is £520.00K, comprised of 88.1% salary and 11.9% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth $104.64K. The average tenure of the management team and the board of directors is 1.2 years and 3.7 years respectively.

Informazioni chiave

Frank Mathias

Amministratore delegato

UK£520.0k

Compenso totale

Percentuale dello stipendio del CEO88.1%
Mandato del CEO1.7yrs
Proprietà del CEO0.02%
Durata media del management1.2yrs
Durata media del Consiglio di amministrazione3.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Frank Mathias rispetto agli utili di Oxford Biomedica?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-UK£142m

Mar 31 2024n/an/a

-UK£150m

Dec 31 2023UK£520kUK£458k

-UK£157m

Compensazione vs Mercato: Frank's total compensation ($USD671.88K) is below average for companies of similar size in the US market ($USD2.42M).

Compensazione vs guadagni: Insufficient data to compare Frank's compensation with company performance.

AMMINISTRATORE DELEGATO

Frank Mathias (62 yo)

1.7yrs

Mandato

UK£520,000

Compensazione

Dr. Frank Mathias is Chief Executive Officer and Director of Oxford Biomedica plc from March 27, 2023. Dr. Mathias was the Chief Executive Officer of Rentschler Biopharma SE from April 2016 until March 202...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
$ 104.6k
Lucinda Crabtree
CFO & Directorless than a yearNessun datoNessun dato
Thierry Cournez
Chief Operating Officer1.1yrsNessun datoNessun dato
Sophia Bolhassan
Head of Investor Relationsno dataNessun datoNessun dato
Natalie Walter
General Counsel & Company Secretary5.5yrsNessun datoNessun dato
Lisa James
Chief People Officer2.6yrsNessun datoNessun dato
Kyriacos Mitrophanous
Chief Innovation Officerless than a yearNessun datoNessun dato
Kati Hudson
Head of Intellectual Property and Contractsno dataNessun datoNessun dato
Sebastien Ribault
Chief Business Officer2yrsNessun datoNessun dato
Mark Caswell
Site Head of UK Operations1.3yrsNessun datoNessun dato
Stephanie Colloud
Site Head & GM of France Operationsless than a yearNessun datoNessun dato
Sabine Sydow
Chief of Staffless than a yearNessun datoNessun dato

1.2yrs

Durata media

51yo

Età media

Gestione esperta: OXBD.F's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
$ 104.6k
Lucinda Crabtree
CFO & Directorless than a yearNessun datoNessun dato
Frederic Doliveux
Non-Executive Chair4.4yrsUK£225.00k0.35%
$ 1.9m
William Langston
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Peter Stern
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Krystof Bankiewicz
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Leone Patterson
Independent Non-Executive Director1.5yrsUK£87.00k0.012%
$ 65.1k
Heather Preston
Independent Non-Executive Director6.7yrsUK£140.00k0.017%
$ 95.8k
Dame Davies
Senior Independent Director3.7yrsUK£73.00k0.00095%
$ 5.2k
Stuart Henderson
Independent Vice Chair8.4yrsUK£85.00k0.010%
$ 56.8k
Robert Ghenchev
Non-Executive Director5.4yrsNessun datoNessun dato
Namrata Patel
Independent Non-Executive Director2.6yrsUK£65.00k0.0087%
$ 48.0k

3.7yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: OXBD.F's board of directors are considered experienced (3.7 years average tenure).